Replies to post #29560 on Ocata Therapeutics Inc fka OCAT

[rocky301]

harlem,

Last month ACT starting using this verbage " act's blastomere-derived lines"
verses the older "act lines" . The lines affected by any proposed NIH change have always been the 5 blastomere lines..NED 1-4 and MA09. The "blastomere derived" verbage may be used now to link upcoming blastomere patent. Same message as before.

slide 4 Jan 2011..NEW Verbage
http://www.advancedcell.com/documents/0000/0282/ACT_Corp_Pres_2011_OneMed_-_FINAL.pdf

slide 5 Nov 2010 OLD Verbage
http://www.thechairmansblog.com/william-caldwell/wp-content/uploads/2010/12/ACT-Macular-Degeneration-Program.pdf

slide 5 Sept 2010 OLD Verbage
http://www.thechairmansblog.com/william-caldwell/wp-content/uploads/2010/12/ACT-Macular-Degeneration-Program.pdf